The Gold Standard: Achieving Optimal Peptide Purification with Reversed-Phase Chromatography

Unlock the Secrets to High-Purity Synthetic Peptides

Purifying synthetic peptides is a critical step in developing advanced biotherapeutics like GLP-1 receptor agonists. Even with precise synthesis, impurities such as deletions, truncations, and chemical modifications are unavoidable - making purification essential for achieving high purity, optimal yield, and cost efficiency.

Join our webinar to discover why reversed-phase chromatography (RP) remains the gold standard for peptide purification and analysis.

We’ll guide you through the complete lab-scale purification process for a GLP-1 RA using optical detection and show how these strategies can be applied to other synthetic peptide modalities, including radio-labeled peptides, cyclic peptides, peptide antimicrobials, and more. 

Why attend?

• Understand strategies for developing analytical scale biotherapeutic peptide separations 
• Learn techniques for lab-scale preparative synthetic peptide separations and fraction analysis 
• Explore how reversed-phase mobile phase modifiers and chemistries impact peptide separation performance
• Gain practical troubleshooting tips for reversed-phase peptide separations 

Who should attend?

This webinar is designed for professionals in Biopharmaceutical Organizations, CMOs, CDMOs, CROs, as well as Academic and Private Peptide Research Organizations.

Don’t miss this opportunity to elevate your peptide purification expertise!

Presenter: Bill Warren (Principal Consultant Product Manager, Waters Corporation)

Bill received his Masters in Microbiology and Immunology from University of Louisville School of Medicine.

In 1986, joined Waters Corporation as a senior applications chemist involved with the research and development of HPLC, FPLC, and Capillary Electrophoresis applications for the analysis and purification of proteins, peptides, and nucleic acids.

Bill currently is a Principal Consultant Product Manager whose responsibilities involve assisting in the development and commercialization of innovative reagents and chromatography-based technologies for the separation, purification, and characterization of biological molecules.